ATP Assays Market worth $0.5 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223438780 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223438780 Browse in-depth TOC on "ATP Assays Market" 158 - Tables 46 - Figures 222 - Pages ATP Assays Market Scope: The consumables & accessories segment is accounted for largest share of the market during the forecast period On the basis of product, The ATP assays...
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223438780

Browse in-depth TOC on "ATP Assays Market"

158 - Tables
46 - Figures
222 - Pages

ATP Assays Market Scope:

The consumables & accessories segment is accounted for largest share of the market during the forecast period

On the basis of product, The ATP assays market comprises consumables & accessories as well as instruments, with the consumables & accessories segment holding a significant portion. This dominance can be attributed to the the growing demand for tumor testing and cell proliferation (specifically in cancer) driven by an upsurge in chronic diseases, and the frequent procurement of consumables by pharmaceutical and biotechnology firms.

The contamination testing segment accounted for the largest share of the market during the forecast period.

On the basis of application, The ATP assays market is bifurcated into contamination testing, disease testing, and drug delivery & development segments. The significant portion of the contamination testing segment is due to various factors such as  the surge in drug discovery activities following the COVID-19 pandemic, and the necessity for cleaning and disinfecting environmental surfaces in hospitals.

The pharmaceutical & biotechnology segment accounted for the largest share of the market in 2022

On the basis of end users, The ATP assays market is categorized into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutes. The dominance of this segment can be attributed to several key factors. These include the presence of a large number of pharmaceutical players who are making substantial investments in this market, the growing regulatory approvals for cell culture-based vaccines that necessitate the use of ATP assays in contamination testing, the expansion of commercial activities by various pharmaceutical companies, the rising demand for cell and gene therapies to address chronic diseases, and significant research and development efforts in the pharmaceutical & biopharmaceutical sector.

APAC to witness the highest growth during the forecast period.

In 2022, North America accounted for the largest share the ATP assays market, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. The large share of North America can be attributed to the availability of government and private funding for life science research, growing penetration of CROs, comprehensive drug development regulations, and the presence of major players in the ATP assays market in this region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=223438780

ATP Assays Market Dynamics:

Drivers:

Restraints:

Opportunities:

Challenges:

Key Market Players:

The prominent players in this market are Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), Neogen Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest Inc. (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech, LLC (US), Cayman Chemical (US), and Cell Signaling Technology,Inc. (US).

Recent Developments:

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=223438780

ATP Assays Market worth $0.5 billion | MarketsandMarkets

ATP Assays Market Advantages:

These advantages make the ATP assays market a valuable tool in various industries, enabling researchers, scientists, and industry professionals to gain insights into cellular energy metabolism, assess product quality, ensure safety, and support critical decision-making processes.

ATP Assays Market – Report Highlights:

The updated version of the report covers the historical market for ATP Assays for the year 2021, 2022 the estimated market for 2023 and forecast till 2028 along with CAGR from 2021 to 2028.

UPDATED MARKET OVERVIEW:

UPDATED COMPETITIVE LANDSCAPE CHAPTER:

UPDATED FINANCIAL INFORMATION/PRODUCT PORTFOLIOS OF PLAYERS:

UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS:

ADDITION OF RECESSION IMPACT:

Related Reports:

Cell Based Assays Market - Global Forecasts to 2028

Cell Culture Market - Global Forecasts to 2028

Cell Therapy Technologies Market - Global Forecasts to 2027

Cell Analysis Market - Global Forecasts to 2027

Stem Cell Assay Market - Global Forecasts to 2027

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/atp-assay-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/atp-assay.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/atp-assays-market-worth-0-5-billion--marketsandmarkets-301865508.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;